| rheumatoid arthritis | Q187255 |
| P2293 | genetic association | IL6R | Q18027836 |
| Q38406451 | "Quiet Reflections" by an Artist With Seropositive Rheumatoid Arthritis, Highlighting the Potential Role of Cadmium Inhalation in the Workplace as a Trigger for Rheumatoid Arthritis |
| Q94552775 | 28. Acute gout with normal inflammatory markers in a seropositive rheumatoid arthritis on longstanding tocilizumab |
| Q94552546 | 93. Recurrent infections in a patient treated with biologic therapy for seropositive rheumatoid arthritis |
| Q43284365 | A 65-year-old man with longstanding seropositive rheumatoid arthritis and lower extremity ulceration |
| Q33553069 | A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis |
| Q33982255 | A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis |
| Q69648243 | A patient with seropositive rheumatoid arthritis |
| Q70112641 | A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis |
| Q92926260 | A study to correlate the serum levels of interleukin 6 with the disease activity indices (CDAI and DAS28 ESR) in seropositive rheumatoid arthritis patients |
| Q73393148 | ABO and Rh blood group distribution in seropositive rheumatoid arthritis |
| Q71493198 | Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome |
| Q46808257 | Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. |
| Q69439854 | Analyses of HLA linkage in white families with multiple cases of seropositive rheumatoid arthritis |
| Q85000043 | Antecubital fossa cyst in longstanding seropositive rheumatoid arthritis |
| Q91819801 | Anti-Interleukin-6 receptor therapy-induced cutaneous symptoms resembling purpura fulminans in a patient with seropositive rheumatoid arthritis |
| Q83656449 | Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis |
| Q33981648 | Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis |
| Q50897297 | Association between functional Fc receptor-like 3 (FCRL3) -169 C/T polymorphism and susceptibility to seropositive rheumatoid arthritis in Asians: a meta-analysis. |
| Q54633346 | Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients. |
| Q97068535 | Association of acute myocardial infarction with seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study |
| Q46090239 | Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort |
| Q46216794 | Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment. |
| Q31078960 | Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis |
| Q91503437 | Blood Pressure Trends in Patients With Seropositive Rheumatoid Arthritis Compared With Controls Without Rheumatoid Arthritis: A Retrospective Cohort Study |
| Q56895242 | CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis |
| Q28389873 | Cadmium, one of the villains behind the curtain: has exposure to cadmium helped to pull the strings of seropositive rheumatoid arthritis pathogenesis all along? |
| Q50969877 | Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. |
| Q98294748 | Challenges and Opportunities: Using Omics to Generate Testable Insights into Pathogenic Mechanisms in Preclinical Seropositive Rheumatoid Arthritis |
| Q55166388 | Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study. |
| Q50941620 | Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome. |
| Q70791691 | Combination drug therapy of seropositive rheumatoid arthritis |
| Q45234571 | Comparative analysis of seronegative and seropositive rheumatoid arthritis regarding some epidemiological and anamnestic characteristics. |
| Q60054288 | Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial |
| Q36171802 | Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort |
| Q51665595 | Comparison of seronegative and seropositive rheumatoid arthritis with regard to some clinical characteristics. |
| Q93803722 | Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis |
| Q73521049 | Continuous progression of radiological destruction in seropositive rheumatoid arthritis |
| Q92190944 | Correction to: Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis |
| Q55277025 | Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study. |
| Q92091128 | Correction: Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population |
| Q73402391 | Crohn's disease associated with seropositive rheumatoid arthritis |
| Q34103237 | Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk |
| Q67824475 | Cytomorphological, ultrastructural and immunological characteristics of the ovialsyn fluid in seropositive rheumatoid arthritis |
| Q46714220 | De novo seropositive rheumatoid arthritis during immunosuppressive treatment after kidney transplantation |
| Q36808606 | Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis |
| Q70304702 | Differential patterns of in vitro IgM rheumatoid factor synthesis in seronegative and seropositive rheumatoid arthritis |
| Q92260568 | Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis |
| Q45971801 | Diffuse chronic leptomeningitis with seropositive rheumatoid arthritis: report of a case successfully treated as rheumatoid leptomeningitis. |
| Q69170643 | Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families |
| Q80062133 | Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort |
| Q70211050 | Expression of large quantities of rheumatoid factor major cross-reactive idiotype in the serum of adults with seropositive rheumatoid arthritis |
| Q60301864 | Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis |
| Q104109184 | Factors Associated with Objectively Measured Physical Activity in Patients with Seropositive Rheumatoid Arthritis |
| Q60717452 | False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis |
| Q77411969 | False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis |
| Q59922398 | Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes |
| Q37693227 | Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. |
| Q90582882 | Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study |
| Q84292206 | Genetic association of CCR5 promoter single nucleotide polymorphism in seronegative and seropositive rheumatoid arthritis |
| Q93071537 | Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept |
| Q77701970 | HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population |
| Q39985494 | Heart disease in patients with seropositive rheumatoid arthritis; a controlled autopsy study and review |
| Q71442085 | High incidence of spontaneous Ig-producing lymphocytes in peripheral blood and synovial fluid of patients with active seropositive rheumatoid arthritis |
| Q70301736 | Histamine-triggered localized vasculitis in patients with seropositive rheumatoid arthritis |
| Q72742674 | How often is seropositive rheumatoid arthritis an erosive disease? A 17-year followup study |
| Q43590228 | IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders |
| Q88594222 | Image analysis of fibrosis in labial salivary glands of patients with systemic autoimmune diseases. Close correlation of lobular fibrosis to seropositive rheumatoid arthritis and increased anti-CCP and RF titres in the serum |
| Q68814839 | Increased frequency of Gm(1,2;21) phenotype in HLA-DR4 positive seropositive rheumatoid arthritis |
| Q35638708 | Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis |
| Q46229308 | Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage |
| Q71548082 | Increased responsiveness of rheumatoid factor-producing B cells in seronegative and seropositive rheumatoid arthritis |
| Q73338696 | Increased serum levels of soluble CD44-isoform v5 in rheumatic diseases are restricted to seropositive rheumatoid arthritis |
| Q90341768 | Individuals at risk of seropositive rheumatoid arthritis: the evolving story |
| Q45959281 | Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. |
| Q69522138 | Is seropositive rheumatoid arthritis becoming less severe? |
| Q86298995 | Left-Sided Flank Pain, Fevers, and Fatigue in a 26-Year-Old Male With Seropositive Rheumatoid Arthritis |
| Q34700683 | Long-term results of arthroscopic synovectomy for seropositive rheumatoid arthritis: 6-16 year review |
| Q103028924 | Menopausal factors and risk of seropositive rheumatoid arthritis in postmenopausal women: a nationwide cohort study of 1.36 million women |
| Q95522076 | Methotrexate-induced accelerated nodulosis in seropositive rheumatoid arthritis |
| Q69378969 | Molecular analysis of HLA-D region genes in seropositive rheumatoid arthritis |
| Q70348698 | Mononuclear phagocyte system Fc-receptor function in patients with seropositive rheumatoid arthritis |
| Q60917927 | Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study |
| Q61703904 | Multiple myeloma masquerading as severe seropositive rheumatoid arthritis with subcutaneous nodules and mononeuritis multiplex |
| Q72629568 | Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes |
| Q70272418 | Nutritional habits of patients suffering from seropositive rheumatoid arthritis: a screening of 93 Dutch patients |
| Q72838984 | On the course of seropositive rheumatoid arthritis during and after long-term gold therapy |
| Q44582597 | Patterns of radiographic outcomes in early, seropositive rheumatoid arthritis: a baseline analysis |
| Q91338406 | Perinuclear Antineutrophil Cytoplasmic Antibodies Vasculitis Presenting as Pulmonary-Renal Syndrome in a Patient With a History of Seropositive Rheumatoid Arthritis |
| Q41936904 | Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination. |
| Q74002478 | Prediction of 20-year outcome at onset of seropositive rheumatoid arthritis |
| Q86040241 | Progressive intraparenchymal lung nodules dissemination in a heavy smoker and seropositive rheumatoid arthritis suspected of tuberculosis relapse |
| Q89554632 | Questions on 'Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population' by Guo et al |
| Q70189372 | Radiographic visualisation of seropositive rheumatoid arthritis in carriers of HLA-B27 |
| Q36334333 | Recurrent constrictive pericarditis associated with seropositive rheumatoid arthritis: A case report |
| Q92778454 | Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients |
| Q85847564 | Relevant incidence of cervical arthritis in patients with erosive seropositive rheumatoid arthritis even today |
| Q94550923 | Response to: 'Questions on 'Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population' by Guo et al' by Regueiro and Gonzalez |
| Q42697400 | Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study. |
| Q76682966 | SERONEGATIVE AND SEROPOSITIVE RHEUMATOID ARTHRITIS: CLINICAL, RADIOLOGICAL, AND BIOCHEMICAL DIFFERENCES |
| Q92764680 | Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population |
| Q46222753 | Seronegative and seropositive rheumatoid arthritis treated with rituximab. |
| Q57732166 | Seronegative and seropositive rheumatoid arthritis: radiographic differences |
| Q69016513 | Seronegative and seropositive rheumatoid arthritis: similar diseases |
| Q59697451 | Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations |
| Q92140424 | Seropositive Rheumatoid Arthritis Presenting with Reversible Parkinsonism and Dysphagia |
| Q64968435 | Seropositive Rheumatoid Arthritis with Very Unusual X-ray Findings. |
| Q44503344 | Seropositive rheumatoid arthritis associated with Crohn's disease |
| Q33569720 | Seropositive rheumatoid arthritis associated with decreased diffusion capacity of the lung |
| Q34184667 | Seropositive rheumatoid arthritis in a female patient with sensory neuropathy |
| Q41927062 | Seropositive rheumatoid arthritis in a patient with cystic fibrosis |
| Q69448538 | Seropositive rheumatoid arthritis in monozygotic twin sisters carrying HLA-DR4 or DR4 associated with B27 |
| Q40622543 | Seropositive rheumatoid arthritis with dermatomyositis sine myositis, angioimmunoblastic lymphadenopathy with dysproteinemia-type T cell lymphoma, and B cell lymphoma of the oropharynx. |
| Q74097214 | Seropositive rheumatoid arthritis with interstitial lung disease in giant cell arteritis |
| Q72164567 | Similarities and differences of seronegative and seropositive rheumatoid arthritis based on our clinical material |
| Q91239387 | Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity |
| Q43048694 | Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. |
| Q95842122 | Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis |
| Q38216971 | T cell ALL presenting as seropositive rheumatoid arthritis: case report and review of the literature on seropositive paraneoplastic arthritis |
| Q67951157 | Temporal arteritis in seropositive rheumatoid arthritis with rheumatoid nodule |
| Q45928777 | The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers. |
| Q39029106 | The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting |
| Q73356115 | The impact of HLA-DRB1*0405 on disease severity in Korean patients with seropositive rheumatoid arthritis |
| Q34307377 | The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner |
| Q78124754 | Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial |
| Q41918654 | Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine |
| Q82424527 | Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone |
| Q72750749 | Wa idiotype in seropositive rheumatoid arthritis |
| Q73168883 | Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study |
| Q37707491 | Workability and Muscle Strength in Patients With Seropositive Rheumatoid Arthritis: Survey Study Protocol. |
| Q69876177 | [Correction of immunoregulatory disorders in seronegative and seropositive rheumatoid arthritis] |
| Q53605513 | [Dyspnea of undetermined origin. Fibrosing alveolitis (FA) in seropositive rheumatoid arthritis (RA)]. |
| Q70994639 | [Immunological disorders in seronegative and seropositive rheumatoid arthritis] |
| Q83632105 | [Infliximab in the treatment of necrotizing scleritis associated to seropositive rheumatoid arthritis] |
| Q73651133 | [Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A] |
| Q18027836 | IL6R | genetic association | P2293 |
| Poliartrite sieropositiva per il fattore reumatoide | wikipedia |
Search more.